Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Patiromer to Enable Plant-Rich Diet in CKD
NCT03183778Phase 4Completed
- Sponsor
- NYU Langone Health
- Start
- Mar 2018
- Primary completion
- Aug 2019
- Modality
- Polymer-based Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of patiromer in hyperkalemia, sponsored by NYU Langone Health. Started Mar 2018; status: completed.
02
Drugs
patiromer
03
Conditions
hyperkalemia
Beyond the preview
Go deeper on NCT03183778.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03183778.